InvestorsObserver
×
News Home

Is it Time to Dump InMed Pharmaceuticals Inc (INM) Stock After it Is Up 2.83% in a Week?

Tuesday, October 04, 2022 03:13 PM | InvestorsObserver Analysts

Mentioned in this article

Is it Time to Dump InMed Pharmaceuticals Inc (INM) Stock After it Is Up 2.83% in a Week?

InMed Pharmaceuticals Inc (INM) stock is higher by 2.83% over the past week and gets a Neutral rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,neutral
InMed Pharmaceuticals Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on INM!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With INM Stock Today?

InMed Pharmaceuticals Inc (INM) stock is trading at $6.90 as of 3:05 PM on Tuesday, Oct 4, a rise of $0.37, or 5.67% from the previous closing price of $6.53. The stock has traded between $6.27 and $6.92 so far today. Volume today is below average. So far 109,455 shares have traded compared to average volume of 2,007,266 shares. To see InvestorsObserver's Sentiment Score for InMed Pharmaceuticals Inc click here.

More About InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others. Click Here to get the full Stock Report for InMed Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App